[
  {
    "ts": null,
    "headline": "insitro Extends Research Collaboration with Bristol Myers Squibb Leveraging insitro’s ChemML Discovery Platform",
    "summary": "SOUTH SAN FRANCISCO, Calif., October 14, 2025--insitro, a pioneer in machine learning–driven drug discovery and development, and Bristol Myers Squibb (NYSE: BMY), today announced the next phase of their collaboration to discover new molecules with potential as new treatments for amyotrophic lateral sclerosis (ALS).",
    "url": "https://finnhub.io/api/news?id=c6bb6a8df3965fb7b8b727494ead1176b8d02fdbae74fde5bd9805ad00884bec",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760472000,
      "headline": "insitro Extends Research Collaboration with Bristol Myers Squibb Leveraging insitro’s ChemML Discovery Platform",
      "id": 137094401,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "SOUTH SAN FRANCISCO, Calif., October 14, 2025--insitro, a pioneer in machine learning–driven drug discovery and development, and Bristol Myers Squibb (NYSE: BMY), today announced the next phase of their collaboration to discover new molecules with potential as new treatments for amyotrophic lateral sclerosis (ALS).",
      "url": "https://finnhub.io/api/news?id=c6bb6a8df3965fb7b8b727494ead1176b8d02fdbae74fde5bd9805ad00884bec"
    }
  },
  {
    "ts": null,
    "headline": "I-Mab Biopharma Stock: Caution Warranted After Huge Surge",
    "summary": "I-Mab Biopharma surged on promising givastomig results in gastric cancer. Click for my updated look at IMAB stock and why I am remaining neutral.",
    "url": "https://finnhub.io/api/news?id=b80c05aac930259c2b7cffa31faa8a5ffd8940a4dfeb13891be07fce641a90a0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760465752,
      "headline": "I-Mab Biopharma Stock: Caution Warranted After Huge Surge",
      "id": 137089117,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1295160689/image_1295160689.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "I-Mab Biopharma surged on promising givastomig results in gastric cancer. Click for my updated look at IMAB stock and why I am remaining neutral.",
      "url": "https://finnhub.io/api/news?id=b80c05aac930259c2b7cffa31faa8a5ffd8940a4dfeb13891be07fce641a90a0"
    }
  },
  {
    "ts": null,
    "headline": "Josh Brown Pitches Best AI Stock ‘Not a Lot of People Know About’",
    "summary": "We recently published Top 10 Trending Stock Ratings and Calls as Tom Lee Says Latest Selloff is a Buying Opportunity. Veeva Systems Inc. (NYSE:VEEV) is one of the top trending stock ratings and calls. Josh Brown from CNBC recently talked about why he added VEEV to his best stock ideas list. Veeva Systems provides cloud-based […]",
    "url": "https://finnhub.io/api/news?id=6b9a964ec06294c35068187c382f703181df58e0ea59b371160df7ec35b86d71",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760465313,
      "headline": "Josh Brown Pitches Best AI Stock ‘Not a Lot of People Know About’",
      "id": 137085709,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "We recently published Top 10 Trending Stock Ratings and Calls as Tom Lee Says Latest Selloff is a Buying Opportunity. Veeva Systems Inc. (NYSE:VEEV) is one of the top trending stock ratings and calls. Josh Brown from CNBC recently talked about why he added VEEV to his best stock ideas list. Veeva Systems provides cloud-based […]",
      "url": "https://finnhub.io/api/news?id=6b9a964ec06294c35068187c382f703181df58e0ea59b371160df7ec35b86d71"
    }
  },
  {
    "ts": null,
    "headline": "BMY Slips Below 50-Day SMA: Buy, Sell or Hold the Stock?",
    "summary": "Bristol Myers stock slips below its 50-day average as generic pressure, high debt, and trimmed earnings outlook weigh on sentiment",
    "url": "https://finnhub.io/api/news?id=7ea5c5af61855618f46bf786620e8351a6b6c0cbb6aba99b5a28b24ec7ca7fc2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760450460,
      "headline": "BMY Slips Below 50-Day SMA: Buy, Sell or Hold the Stock?",
      "id": 137085744,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol Myers stock slips below its 50-day average as generic pressure, high debt, and trimmed earnings outlook weigh on sentiment",
      "url": "https://finnhub.io/api/news?id=7ea5c5af61855618f46bf786620e8351a6b6c0cbb6aba99b5a28b24ec7ca7fc2"
    }
  },
  {
    "ts": null,
    "headline": "Every Word Matters: The Next Chapter of Our Universal Patient Language",
    "summary": "Originally published on BMS.com in recognition of Health Literacy Month, the following article highlights how Bristol Myers Squibb's Universal Patient Language (UPL) program is advancing clearer, more compassionate and empowering health communication. ...",
    "url": "https://finnhub.io/api/news?id=c64b6796c68f84ed227e401edebd40756d811f10afa9c840e46b437df47029e4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760439600,
      "headline": "Every Word Matters: The Next Chapter of Our Universal Patient Language",
      "id": 137086058,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Originally published on BMS.com in recognition of Health Literacy Month, the following article highlights how Bristol Myers Squibb's Universal Patient Language (UPL) program is advancing clearer, more compassionate and empowering health communication. ...",
      "url": "https://finnhub.io/api/news?id=c64b6796c68f84ed227e401edebd40756d811f10afa9c840e46b437df47029e4"
    }
  },
  {
    "ts": null,
    "headline": "What to Expect From Bristol-Myers Squibb's Next Quarterly Earnings Report",
    "summary": "Bristol-Myers Squibb is set to release its third-quarter results by the end of this month, and analysts expect a notable double-digit drop in earnings.",
    "url": "https://finnhub.io/api/news?id=ed9d907b8bc02c72995c4db082bac3295b6271e0af1bbbb266abefc1abe20ccc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760420746,
      "headline": "What to Expect From Bristol-Myers Squibb's Next Quarterly Earnings Report",
      "id": 137086059,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol-Myers Squibb is set to release its third-quarter results by the end of this month, and analysts expect a notable double-digit drop in earnings.",
      "url": "https://finnhub.io/api/news?id=ed9d907b8bc02c72995c4db082bac3295b6271e0af1bbbb266abefc1abe20ccc"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb (BMY): Strong Growth Pipeline Supports High-Yield Dividend",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is included among the 12 Best Dividend Stocks with Yields Above 4%. Bristol-Myers Squibb Company (NYSE:BMY), headquartered i‍n New Jersey, is a globa‌l pharmaceutical leader‍ devel⁠oping prescription drug‌s a⁠cross a‍r​eas su‌ch as oncol‌ogy, hematology, car⁠dio‌logy, immunology, and neuroscience. The company’s recent strategy emphasizes expanding its “Growth Portf‍olio” through new product⁠ la⁠unches, […]",
    "url": "https://finnhub.io/api/news?id=415193440cee30e5eac60310d6a470a3295dbced0b4b139387bc76380d6f4a1e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760411049,
      "headline": "Bristol-Myers Squibb (BMY): Strong Growth Pipeline Supports High-Yield Dividend",
      "id": 137074468,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is included among the 12 Best Dividend Stocks with Yields Above 4%. Bristol-Myers Squibb Company (NYSE:BMY), headquartered i‍n New Jersey, is a globa‌l pharmaceutical leader‍ devel⁠oping prescription drug‌s a⁠cross a‍r​eas su‌ch as oncol‌ogy, hematology, car⁠dio‌logy, immunology, and neuroscience. The company’s recent strategy emphasizes expanding its “Growth Portf‍olio” through new product⁠ la⁠unches, […]",
      "url": "https://finnhub.io/api/news?id=415193440cee30e5eac60310d6a470a3295dbced0b4b139387bc76380d6f4a1e"
    }
  }
]